# Kyongbo Pharmaceutical Co., Ltd. – FDA Inspection, Dec 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/56e3c3e7-a77a-49a6-97b8-9515a55dc75c
Source feed: FDA_Inspections

> FDA inspection 1036989 of Kyongbo Pharmaceutical Co., Ltd., December 01, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036989
- Company Name: Kyongbo Pharmaceutical Co., Ltd.
- Inspection Date: 2017-12-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1295018 - 2025-11-11](https://www.keypedia.com/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/5ccde842-fa1b-48e6-a19e-bf02447ba280)
- FDA Inspection 1112024 - 2019-12-06
- FDA Inspection 961652 - 2016-02-26
- FDA Inspection 736571 - 2011-06-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)

Company: https://www.keypedia.com/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
